Results 231 to 240 of about 796,036 (401)
Study of risk factors in patients with aortic stenosis [PDF]
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroduction. Aortic valve stenosis is commonly considered a degenerative disorder with no recommended preventive intervention. With increased life expectancy
Mazur-Nicorici, Lucia, Vlad, Ariana
core
Abstract Aims Ischaemic mitral regurgitation (MR) is a dynamic condition influenced by global and regional left ventricular remodelling as well as mitral valvular deformation. Exercise testing plays a substantial role in assessing the haemodynamic relevance of MR and is recommended by current guidelines.
Maximilian Spieker+14 more
wiley +1 more source
Calcific Embolization Associated with Valvotomy for Calcific Aortic Stenosis [PDF]
Keith E. Holley+3 more
openalex +1 more source
Iconoclasts topple adaptive myocardial hypertrophy in aortic stenosis [PDF]
Buermans, H.P.J., Paulus, W.J.S.
core +2 more sources
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal+17 more
wiley +1 more source
Operative Treatment of Aortic Stenosis in the Adult [PDF]
J. Gordon Scannell+4 more
openalex +1 more source
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman+9 more
wiley +1 more source
A Review of “Access to Care” Issues in Aortic Stenosis Patients: A Negative Report Card
The identification and management of patients with aortic stenosis exist along a continuum that includes healthy living, latent progression, diagnosis, treatment, and posttreatment recovery.
Adam M. Reisman, MD+1 more
doaj
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi+21 more
wiley +1 more source